(Q42981587)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14642624%20AND%20SRC:MED&resulttype=core&format=json

21 December 2019

title

In overweight patients with chronic hepatitis C, circulating insulin is associated with hepatic fibrosis: implications for therapy (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14642624%20AND%20SRC:MED&resulttype=core&format=json

21 December 2019

0 references

1 reference

1 reference

1 reference

1 reference

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14642624%20AND%20SRC:MED&resulttype=core&format=json

21 December 2019

Johannes B. Prins

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14642624%20AND%20SRC:MED&resulttype=core&format=json

21 December 2019

Andrew D. Clouston

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14642624%20AND%20SRC:MED&resulttype=core&format=json

21 December 2019

Ingrid Hickman

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14642624%20AND%20SRC:MED&resulttype=core&format=json

21 December 2019

author name string

Susan Ash

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14642624%20AND%20SRC:MED&resulttype=core&format=json

21 December 2019

David M Purdie

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14642624%20AND%20SRC:MED&resulttype=core&format=json

21 December 2019

Julie R Jonsson

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14642624%20AND%20SRC:MED&resulttype=core&format=json

21 December 2019

publication date

1 December 2003

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14642624%20AND%20SRC:MED&resulttype=core&format=json

21 December 2019

published in

Journal of Hepatology

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14642624%20AND%20SRC:MED&resulttype=core&format=json

21 December 2019

volume

39

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14642624%20AND%20SRC:MED&resulttype=core&format=json

21 December 2019

issue

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14642624%20AND%20SRC:MED&resulttype=core&format=json

21 December 2019

page(s)

1042-1048

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14642624%20AND%20SRC:MED&resulttype=core&format=json

Fibrosis in chronic hepatitis C correlates significantly with body mass index and steatosis

21 December 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2803%2900463-X

7 January 2021

Steatosis accelerates the progression of liver damage of chronic hepatitis C patients and correlates with specific HCV genotype and visceral obesity

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2803%2900463-X

7 January 2021

Analysis of histopathological manifestations of chronic hepatitis C virus infection with respect to virus genotype

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2803%2900463-X

7 January 2021

Steatosis in chronic hepatitis C: relative contributions of obesity, diabetes mellitus, and alcohol

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2803%2900463-X

7 January 2021

NASH and insulin resistance: Insulin hypersecretion and specific association with the insulin resistance syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2803%2900463-X

7 January 2021

Nonalcoholic fatty liver disease: a feature of the metabolic syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2803%2900463-X

7 January 2021

Association of nonalcoholic fatty liver disease with insulin resistance.

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2803%2900463-X

7 January 2021

Nonalcoholic fatty liver disease: predictors of nonalcoholic steatohepatitis and liver fibrosis in the severely obese

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2803%2900463-X

7 January 2021

High glucose and hyperinsulinemia stimulate connective tissue growth factor expression: a potential mechanism involved in progression to fibrosis in nonalcoholic steatohepatitis

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2803%2900463-X

7 January 2021

Insulin and insulin-like growth factor-1 stimulate proliferation and type I collagen accumulation by human hepatic stellate cells: differential effects on signal transduction pathways

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2803%2900463-X

7 January 2021

Leptin augments inflammatory and profibrogenic responses in the murine liver induced by hepatotoxic chemicals

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2803%2900463-X

7 January 2021

Leptin in hepatic fibrosis: evidence for increased collagen production in stellate cells and lean littermates of ob/ob mice

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2803%2900463-X

7 January 2021

Leptin receptor-mediated signaling regulates hepatic fibrogenesis and remodeling of extracellular matrix in the rat.

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2803%2900463-X

7 January 2021

Leptin is essential for the hepatic fibrogenic response to chronic liver injury

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2803%2900463-X

7 January 2021

Modulation of insulin activities by leptin

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2803%2900463-X

7 January 2021

Leptin enhances wound re-epithelialization and constitutes a direct function of leptin in skin repair

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2803%2900463-X

7 January 2021

Transdifferentiation of rat hepatic stellate cells results in leptin expression

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2803%2900463-X

7 January 2021

Leptin and liver fibrosis: A matter of fat

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2803%2900463-X

7 January 2021

Classification of chronic viral hepatitis: a need for reassessment

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2803%2900463-X

7 January 2021

Homeostasis model assessment: insulin resistance and ?-cell function from fasting plasma glucose and insulin concentrations in man

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2803%2900463-X

7 January 2021

Homeostasis model assessment closely mirrors the glucose clamp technique in the assessment of insulin sensitivity: studies in subjects with various degrees of glucose tolerance and insulin sensitivity.

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2803%2900463-X

7 January 2021

Hepatitis C virus induced hypobetalipoproteinemia: a possible mechanism for steatosis in chronic hepatitis C.

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2803%2900463-X

7 January 2021

Hyperinsulinism of hepatic cirrhosis: Diminished degradation or hypersecretion?

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2803%2900463-X

7 January 2021

Effect of physiologic hyperinsulinemia on glucose and lipid metabolism in cirrhosis

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2803%2900463-X

7 January 2021

Contribution of reduced insulin sensitivity and secretion to the pathogenesis of hepatogenous diabetes: effect of liver transplantation

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2803%2900463-X

7 January 2021

Risk factors for diabetes mellitus and early insulin resistance in chronic hepatitis C.

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2803%2900463-X

7 January 2021

Severity of HCV-induced liver damage alters glucose homeostasis in noncirrhotic patients with chronic HCV infection

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2803%2900463-X

7 January 2021

Diagnosing insulin resistance in the general population

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2803%2900463-X

7 January 2021

Association of diabetes mellitus and chronic hepatitis C virus infection.

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2803%2900463-X

7 January 2021

Further evidence for an association between non-insulin-dependent diabetes mellitus and chronic hepatitis C virus infection

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2803%2900463-X

7 January 2021

Increased risk of type 2 diabetes in noncirrhotic patients with chronic hepatitis C virus infection

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2803%2900463-X

7 January 2021

Prevalence of type 2 diabetes mellitus among persons with hepatitis C virus infection in the United States

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2803%2900463-X

7 January 2021

Insulin resistance differentially affects the PI 3-kinase- and MAP kinase-mediated signaling in human muscle

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2803%2900463-X

7 January 2021

Molecular mechanisms for the control of translation by insulin

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2803%2900463-X

7 January 2021

Translational regulation of renal proximal tubular epithelial cell transforming growth factor-beta1 generation by insulin

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2803%2900463-X

7 January 2021

Regulation of circulating soluble leptin receptor levels by gender, adiposity, sex steroids, and leptin: observational and interventional studies in humans

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2803%2900463-X

7 January 2021

Plasma leptin and TNF-alpha levels in chronic hepatitis C patients and their relationship to hepatic fibrosis

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2803%2900463-X

7 January 2021

Leptin has no role in determining severity of steatosis and fibrosis in patients with chronic hepatitis C.

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2803%2900463-X

7 January 2021

Serum leptin in NASH correlates with hepatic steatosis but not fibrosis: a manifestation of lipotoxicity?

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2803%2900463-X

7 January 2021

Hepatitis C virus core protein inhibits microsomal triglyceride transfer protein activity and very low density lipoprotein secretion: a model of viral-related steatosis

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2803%2900463-X

7 January 2021

Hepatocyte steatosis is a cytopathic effect of hepatitis C virus genotype 3.

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2803%2900463-X

7 January 2021

Effect of weight reduction on liver histology and biochemistry in patients with chronic hepatitis C.

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2803%2900463-X

7 January 2021

10.1016/S0168-8278(03)00463-X

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14642624%20AND%20SRC:MED&resulttype=core&format=json

21 December 2019

1 reference